Build or Buy Challenge: 6 advantages of using a pre-qualified, fully customisable GMP environment

As global patient populations increase, there are a growing number of challenges and demands faced by pharma and biotech companies to ensure product is delivered in a timely and cost effective way. When capacity is at a premium, significant investment decisions must be made to ultimately determine the expansion of existing facilities, headcounts and technology choices necessary to maintain supply.

An alternative solution to the ‘build or buy’ decision is the use of readily available, pre-qualified GMP facilities which can be fully tailored to suit individual needs and provide reassurance that product will be delivered on time and on budget.